Daxor Corp DXR:NYSE American

RT Quote | NYSE American | USD
Last | 4:00 PM EST
11.79quote price arrow up+0.30 (+2.65%)
Volume
983
52 week range
7.85 - 24.08

...

Loading . . .

KEY STATS

  • Open11.88
  • Day High12.04
  • Day Low11.59
  • Prev Close11.49
  • 52 Week High24.08
  • 52 Week High Date07/17/20
  • 52 Week Low7.85
  • 52 Week Low Date02/28/20
  • Market Cap45.86M
  • Shares Out3.89M
  • 10 Day Average Volume0.01M
  • Dividend0.03
  • Dividend Yield0.25%
  • Beta-1.05
  • 1 Year % Change22.8

RATIOS/PROFITABILITY

  • EPS (TTM)-1.16
  • P/E (TTM)-10.15
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-291,670.00
  • ROE (MRQ)-36.19%
  • Revenue (MRQ)310,000.00
  • Gross Margin (MRQ)-57.77%
  • Net Margin (MRQ)-1,463.21%
  • Debt To Equity (MRQ)8.11%

EVENTS

  • Earnings Date-
  • Ex Div Date01/05/2018
  • Div Amount0.03
  • Split Date-
  • Split Factor-

Latest Daxor Corp News

There is no recent news for this security.

Latest DXR News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The Company focuses on the development of the Blood Volume Analyzer (BVA) -100, an instrument that rapidly and accurately measures human blood volume. The Company’s instrument is used in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.The Company also owns the Daxor Oak Ridge Operations (DORO) facility in Oak Ridge...
Michael Feldschuh
Chairman
Robert Michel CPA
Chief Financial Officer
Address
350 5th Ave Ste 4740
New York, NY
10118-0002
United States